Scalable synthesis and structural characterization of reversible KLK6 inhibitors
Andreas Baumann1, Daniel Isak1, Jasmin Lohbeck1
1Cancer Drug Development Group, German Cancer Research Center (DKFZ) Im Neuenheimer Feld 280 69120 Heidelberg Germany aubry.miller@dkfz.de.
Abstract:
Scalable asymmetric syntheses of two kallikrein-related protease 6 (KLK6) inhibitors are reported. The inhibitors are assembled by linking enantiomerically enriched fragments via amide bond formation, followed by conversion of a cyano group to an amidine. One fragment, an amine, was prepared using the Ellman auxiliary, and a lack of clarity in the literature regarding the stereochemical outcome of this reaction was solved via X-ray crystallographic analysis of two derivatives. Complexes of the inhibitors bound to human KLK6 were solved by X-ray crystallography, revealing the binding poses.


